Across Cancer Types

We are committed to our focus disease areas of lung and gastrointestinal cancers but are guided by science and pursue opportunities in other areas of unmet need, to deliver first-in-class treatments that can transform patient lives. Our commitment to innovation has already resulted in pioneering treatments and we are advancing a unique pipeline of cancer cell directed agents, immuno-oncology therapies and combination approaches to help win the fight against cancer.

Leading science in Oncology from Boehringer Ingelheim on Vimeo

Latest Articles on Across Cancer Types

Our Four Pillars of Cancer Immunology Research

Find out more about the four cornerstones of our cancer immunology research approach.

[閱讀全文](/content/tw/our-four-pillars-cancer-immunology-research "Teaser headline Our Four Pillars of Cancer Immunology Research"/index.html)

How scientific congresses drive patient benefit

What is happening behind the doors of congress centers? How do patients benefit from the participation of pharmaceutical representatives? Let’s shed some light.

閱讀全文